Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in the Secondary Prevention of Acute Coronary Syndrome

Author： Brosa M.

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.14, 2002-01, pp. : 979-987

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in Patients with Acute Coronary Syndrome in Poland: Modelling Study from the Hospital Perspective

By Orlewska E.

PharmacoEconomics, Vol. 21, Iss. 10, 2003-01 ,pp. : 737-748

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin for Acute Coronary Syndromes: A Canadian Hospital Perspective

By Balen R.M.

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 533-542

Adis International

Access to resources Recommend Favorite

Dermatan Sulfate versus Unfractionated Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Surgery for Cancer: A Cost-Effectiveness Analysis

By Attanasio E.

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 57-68

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Bemiparin Sodium versus Unfractionated Heparin and Oral Anticoagulants in the Acute and Long-Term Treatment of Deep Vein Thrombosis

By Gómez-Outes Antonio

PharmacoEconomics, Vol. 24, Iss. 1, 2006-01 ,pp. : 81-92

Adis International

Access to resources Recommend Favorite

The Cost-Effectiveness of Low-Molecular-Weight Heparin vs Unfractionated Heparin in General and Orthopaedic Surgery: An Analysis for the German Healthcare System

By Szucs T.D. Schramm W.

Pharmacological Research, Vol. 40, Iss. 1, 1999-07 ,pp. : 83-89

Academic Press

Access to resources Recommend Favorite